Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Effects of antenatal melatonin therapy on lung structure in growth-restricted newborn lambs.

Polglase GR, Barbuto J, Allison BJ, Yawno T, Sutherland AE, Malhotra A, Schulze KE, Wallace EM, Jenkin G, Ricardo SD, Miller SL.

J Appl Physiol (1985). 2017 Aug 17:jap.00783.2016. doi: 10.1152/japplphysiol.00783.2016. [Epub ahead of print]

PMID:
28819007
2.

miR-378 reduces mesangial hypertrophy and kidney tubular fibrosis via MAPK signalling.

Wang B, Yao K, Wise AF, Lau R, Shen HH, Tesch GH, Ricardo SD.

Clin Sci (Lond). 2017 Mar 1;131(5):411-423. doi: 10.1042/CS20160571. Epub 2017 Jan 4.

PMID:
28053239
3.

Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airway disease.

Royce SG, Tominaga AM, Shen M, Patel KP, Huuskes BM, Lim R, Ricardo SD, Samuel CS.

Clin Sci (Lond). 2016 Dec 1;130(23):2151-2165. Epub 2016 Sep 19.

PMID:
27647937
4.

Inpp5e suppresses polycystic kidney disease via inhibition of PI3K/Akt-dependent mTORC1 signaling.

Hakim S, Dyson JM, Feeney SJ, Davies EM, Sriratana A, Koenig MN, Plotnikova OV, Smyth IM, Ricardo SD, Hobbs RM, Mitchell CA.

Hum Mol Genet. 2016 Jun 1;25(11):2295-2313. Epub 2016 Apr 7.

PMID:
27056978
5.

Phenotype and Influx Kinetics of Leukocytes and Inflammatory Cytokine Production in Kidney Ischemia/Reperfusion Injury.

Williams TM, Wise AF, Layton DS, Ricardo SD.

Nephrology (Carlton). 2016 Oct 1. doi: 10.1111/nep.12941. [Epub ahead of print]

PMID:
27696567
6.

Renal cellular hypoxia in adenine-induced chronic kidney disease.

Fong D, Ullah MM, Lal JG, Abdelkader A, Ow CP, Hilliard LM, Ricardo SD, Kelly DJ, Evans RG.

Clin Exp Pharmacol Physiol. 2016 Oct;43(10):896-905. doi: 10.1111/1440-1681.12621.

PMID:
27385644
7.

Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis.

Wang B, Yao K, Huuskes BM, Shen HH, Zhuang J, Godson C, Brennan EP, Wilkinson-Berka JL, Wise AF, Ricardo SD.

Mol Ther. 2016 Aug;24(7):1290-301. doi: 10.1038/mt.2016.90. Epub 2016 May 18.

8.

Human mesenchymal stem cells alter the gene profile of monocytes from patients with Type 2 diabetes and end-stage renal disease.

Wise AF, Williams TM, Rudd S, Wells CA, Kerr PG, Ricardo SD.

Regen Med. 2016 Mar;11(2):145-58. doi: 10.2217/rme.15.74. Epub 2015 Nov 6.

PMID:
26544198
9.

Mesenchymal stem cells as novel micro-ribonucleic acid delivery vehicles in kidney disease.

Yao K, Ricardo SD.

Nephrology (Carlton). 2016 May;21(5):363-71. doi: 10.1111/nep.12643. Review.

PMID:
26437381
10.

Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease.

Royce SG, Shen M, Patel KP, Huuskes BM, Ricardo SD, Samuel CS.

Stem Cell Res. 2015 Nov;15(3):495-505. doi: 10.1016/j.scr.2015.09.007. Epub 2015 Sep 25.

11.

M2 macrophage accumulation in the aortic wall during angiotensin II infusion in mice is associated with fibrosis, elastin loss, and elevated blood pressure.

Moore JP, Vinh A, Tuck KL, Sakkal S, Krishnan SM, Chan CT, Lieu M, Samuel CS, Diep H, Kemp-Harper BK, Tare M, Ricardo SD, Guzik TJ, Sobey CG, Drummond GR.

Am J Physiol Heart Circ Physiol. 2015 Sep;309(5):H906-17. doi: 10.1152/ajpheart.00821.2014. Epub 2015 Jun 12.

12.

Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy.

Huuskes BM, Wise AF, Cox AJ, Lim EX, Payne NL, Kelly DJ, Samuel CS, Ricardo SD.

FASEB J. 2015 Feb;29(2):540-53. doi: 10.1096/fj.14-254789. Epub 2014 Nov 13.

13.

The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure.

Jones CV, Alikhan MA, O'Reilly M, Sozo F, Williams TM, Harding R, Jenkin G, Ricardo SD.

Respir Res. 2014 Sep 6;15:110. doi: 10.1186/s12931-014-0110-5.

14.

Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury.

Wise AF, Williams TM, Kiewiet MB, Payne NL, Siatskas C, Samuel CS, Ricardo SD.

Am J Physiol Renal Physiol. 2014 May 15;306(10):F1222-35. doi: 10.1152/ajprenal.00675.2013. Epub 2014 Mar 12.

15.

Establishing the flow cytometric assessment of myeloid cells in kidney ischemia/reperfusion injury.

Williams TM, Wise AF, Alikhan MA, Layton DS, Ricardo SD.

Cytometry A. 2014 Mar;85(3):256-67. doi: 10.1002/cyto.a.22420. Epub 2013 Nov 21.

16.

Does a nephron deficit exacerbate the renal and cardiovascular effects of obesity?

Gurusinghe S, Brown RD, Cai X, Samuel CS, Ricardo SD, Thomas MC, Kett MM.

PLoS One. 2013 Sep 3;8(9):e73095. doi: 10.1371/journal.pone.0073095. eCollection 2013.

17.

Macrophages and CSF-1: implications for development and beyond.

Jones CV, Ricardo SD.

Organogenesis. 2013 Oct 1;9(4):249-60. doi: 10.4161/org.25676. Epub 2013 Jul 29. Review.

18.

Human kidney cell reprogramming: applications for disease modeling and personalized medicine.

O'Neill AC, Ricardo SD.

J Am Soc Nephrol. 2013 Sep;24(9):1347-56. doi: 10.1681/ASN.2012121199. Epub 2013 Aug 15. Review.

19.

A flow cytometric method for the analysis of macrophages in the vascular wall.

Moore JP, Sakkal S, Bullen ML, Kemp-Harper BK, Ricardo SD, Sobey CG, Drummond GR.

J Immunol Methods. 2013 Oct 31;396(1-2):33-43. doi: 10.1016/j.jim.2013.07.009. Epub 2013 Aug 6.

PMID:
23928493
20.

M2 macrophage polarisation is associated with alveolar formation during postnatal lung development.

Jones CV, Williams TM, Walker KA, Dickinson H, Sakkal S, Rumballe BA, Little MH, Jenkin G, Ricardo SD.

Respir Res. 2013 Apr 5;14:41. doi: 10.1186/1465-9921-14-41.

Supplemental Content

Loading ...
Support Center